D-type cyclins
The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Abstract
D-type cyclins couple extracellular signals to the biochemical machinery that governs progression through G1 phase of the mammalian cell division cycle. Induced by growth factor stimulation, D-type cyclins assemble with cyclin-dependent kinases CDK4 and CDK6 to form holoenzymes that facilitate exit from G1 by phosphorylating key substrates, including the retinoblastoma protein. Activation of the holoenzymes is antagonized by polypeptide inhibitors of CDK activity, which are induced by antiproliferative signals. Once cells pass a late G1 restriction point, cyclin-D-dependent kinases are unnecessary for completion of the cell cycle, implying that their primary role is to sense the cell's readiness to replicate DNA and to enforce the commitment to enter S phase.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cyclin D1 forms a complex with CDK4/6 to catalyze phosphorylation of Rb, leading to E2F transcription factor activation and consequent expression of genes required for the G1-S transition (31).”
From A genome-wide screen reveals that Dyrk1A kinase promotes nucleotide excision repair by preventing aberrant overexpression of cyclin D1 and p21 (2023) · cites this paper as [31]
Citations
Cites
WAF1, a potential mediator of p53 tumor suppression
El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., & Vogelstein, B. (1993) · Cell · doi:10.1016/0092-8674(93)90500-p · Cited by 8,321
The p21 Cdk-interacting protein Cip1 is a potent inhibitor of G1 cyclin-dependent kinases.
Wade Harper, J. (1993) · Cell · doi:10.1016/0092-8674(93)90499-g · Cited by 5,651
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650
p21 is a universal inhibitor of cyclin kinases
Xiong, Y., Hannon, G. J., Zhang, H., Casso, D., Kobayashi, R., & Beach, D. (1993) · Nature · doi:10.1038/366701a0 · Cited by 3,368
A cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751
Polyak, K., Lee, M.-H., Erdjument-Bromage, H., Koff, A., Roberts, J. M., Tempst, P., & Massagué, J. (1994) · Cell · doi:10.1016/0092-8674(94)90572-x · Cited by 2,118
p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21
Toyoshima, H., & Hunter, T. (1994) · Cell · doi:10.1016/0092-8674(94)90573-8 · Cited by 2,043
Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M., & Koff, A. (1994) · Genes & Development · doi:10.1101/gad.8.1.9 · Cited by 1,954
Self-citationpl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA
Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/369574a0 · Cited by 1,655
Cyclin D1 is a nuclear protein required for cell cycle progression in G1
Baldin, V, Lukas, J., Marcote, M. J., Pagano, M., & Draetta, G. (1993) · Genes & Development · doi:10.1101/gad.7.5.812 · Cited by 1,614
E2F: a Link Between the Rb Tumor Suppressor Protein and Viral Oncoproteins
Nevins, J. R. (1992) · Science · doi:10.1126/science.1411535 · Cited by 1,506
Dulić, V., Kaufmann, W. K., Wilson, S. J., Tisty, T. D., Lees, E., Harper, J. W., Elledge, S. J., & Reed, S. I. (1994) · Cell · doi:10.1016/0092-8674(94)90379-4 · Cited by 1,465
Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen
Noda, A., Ning, Y., Venable, S. F., Pereira-Smith, O. M., & Smith, J. R. (1994) · Experimental Cell Research · doi:10.1006/excr.1994.1063 · Cited by 1,351
(1993) · Genes & Development · doi:10.1101/gad.7.3.331 · Cited by 1,264
Self-citationColony-stimulating factor 1 regulates novel cyclins during the G1 phase of the cell cycle
Matsushime, H., Roussel, M. F., Ashmun, R. A., & Sherr, C. J. (1991) · Cell · doi:10.1016/0092-8674(91)90101-4 · Cited by 1,167
Self-citationD-type cyclin-dependent kinase activity in mammalian cells.
Matsushime, H., Quelle, D. E., Shurtleff, S. A., Shibuya, M., Sherr, C. J., & Kato, J. Y. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2066 · Cited by 1,064
Self-citationFormation and Activation of a Cyclin E-cdk2 Complex During the G 1 Phase of the Human Cell Cycle
Koff, A., Giordano, A., Desai, D., Yamashita, K., Harper, J. W., Elledge, S., Nishimoto, T., Morgan, D. O., Franza, B. R., & Roberts, J. M. (1992) · Science · doi:10.1126/science.1388288 · Cited by 1,043
Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.
Quelle, D. E., Ashmun, R. A., Shurtleff, S. A., Kato, J. Y., Bar-Sagi, D., Roussel, M. F., & Sherr, C. J. (1993) · Genes & Development · doi:10.1101/gad.7.8.1559 · Cited by 1,032
Self-citationXiong, Y., Zhang, H., & Beach, D. (1992) · Cell · doi:10.1016/0092-8674(92)90518-h · Cited by 1,021
Functional interactions of the retinoblastoma protein with mammalian D-type cyclins
Ewen, M. E., Sluss, H. K., Sherr, C. J., Matsushime, H., Kato, J.-Y., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90136-e · Cited by 1,010
Self-citationResnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669-1679.1994 · Cited by 965
Expression of transcription factor E2F1 induces quiescent cells to enter S phase
Johnson, D. G., Schwarz, J. K., Cress, W. D., & Nevins, J. R. (1993) · Nature · doi:10.1038/365349a0 · Cited by 943
Matsushime, H., Ewen, M. E., Strom, D. K., Kato, J.-Y., Hanks, S. K., Roussel, M. F., & Sherr, C. J. (1992) · Cell · doi:10.1016/0092-8674(92)90360-o · Cited by 897
Self-citationNourse, J., Firpo, E., Flanagan, W. M., Coats, S., Polyak, K., Lee, M.-H., Massague, J., Crabtree, G. R., & Roberts, J. M. (1994) · Nature · doi:10.1038/372570a0 · Cited by 889
Association of human cyclin E with a periodic G1-S phase protein kinase
Dulic, V, Lees, E., & Reed, S. (1992) · Science · doi:10.1126/science.1329201 · Cited by 881
Identification of G1 kinase activity for cdk6, a novel cyclin D partner.
Meyerson, M., & Harlow, E. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.2077 · Cited by 794
Physical interaction of the retinoblastoma protein with human D cyclins
Dowdy, S. F., Hinds, P. W., Louie, K., Reed, S. I., Arnold, A., & Weinberg, R. A. (1993) · Cell · doi:10.1016/0092-8674(93)90137-f · Cited by 744
Kato, J.-Y., Matsuoka, M., Polyak, K., Massague, J., & Sherr, C. J. (1994) · Cell · doi:10.1016/0092-8674(94)90257-7 · Cited by 720
Self-citationThe retinoblastoma gene product regulates progression through the G1 phase of the cell cycle
Goodrich, D. W., Wang, N. P., Qian, Y.-W., Lee, E. Y.-H. P., & Lee, W.-H. (1991) · Cell · doi:10.1016/0092-8674(91)90181-w · Cited by 707
Resnitzky, D., Gossen, M., Bujard, H., & Reed, S. I. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.3.1669 · Cited by 664
A novel cyclin associates with M015/CDK7 to form the CDK-activating kinase
Fisher, R. P., & Morgan, D. O. (1994) · Cell · doi:10.1016/0092-8674(94)90535-5 · Cited by 655
Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair
Li, R., Waga, S., Hannon, G. J., Beach, D., & Stillman, B. (1994) · Nature · doi:10.1038/371534a0 · Cited by 643
p21-containing cyclin kinases exist in both active and inactive states.
Zhang, H., Hannon, G. J., & Beach, D. (1994) · Genes & Development · doi:10.1101/gad.8.15.1750 · Cited by 632
Negative Regulation of G1 in Mammalian Cells: Inhibition of Cyclin E-Dependent Kinase by TGF-β
Koff, A., Ohtsuki, M., Polyak, K., Roberts, J. M., & Massagué, J. (1993) · Science · doi:10.1126/science.8475385 · Cited by 567
Knoblich, J. A., Sauer, K., Jones, L., Richardson, H., Saint, R., & Lehner, C. F. (1994) · Cell · doi:10.1016/0092-8674(94)90239-9 · Cited by 541
TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest
Ewen, M. E., Sluss, H. K., Whitehouse, L. L., & Livingston, D. M. (1993) · Cell · doi:10.1016/0092-8674(93)90723-4 · Cited by 528
Identification of a growth suppression domain within the retinoblastoma gene product.
Qin, X. Q., Chittenden, T., Livingston, D. M., & Kaelin, W. G. (1992) · Genes & Development · doi:10.1101/gad.6.6.953 · Cited by 404
Jiang, W. B., Kahn, S. M., Zhou, P., Zhang, Y., Cacace, A. M., Infante, A. S., Doi, S., Santella, R. M., & Weinstein, I. B. (1993) · PubMed · Cited by 386
Ludlow, J. W., Shon, J., Pipas, J. M., Livingston, D. M., & DeCaprio, J. A. (1990) · Cell · doi:10.1016/0092-8674(90)90590-b · Cited by 381
Cell cycle expression and p53 regulation of the cyclin-dependent kinase inhibitor p21.
Li, Y., Jenkins, C. W., Nichols, M. A., & Xiong, Y. (1994) · PubMed · Cited by 358
Regulation of cyclin D-dependent kinase 4 (cdk4) by cdk4-activating kinase.
Kato, J. Y., Matsuoka, M., Strom, D. K., & Sherr, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.4.2713 · Cited by 298
Self-citationTam, S. W., Theodoras, A. M., Shay, J. W., Draetta, G. F., & Pagano, M. (1994) · PubMed · Cited by 269
Lukas, J., Müller, H., Bartkova, J., Spitkovsky, D., Kjerulff, A. A., Jansen-Dürr, P., Strauss, M., & Bartek, J. (1994) · The Journal of cell biology · doi:10.1083/jcb.125.3.625 · Cited by 269
A cyclin associated with the CDK-activating kinase MO15
Mäkelä, T. P., Tassan, J.-P., Nigg, E. A., Frutiger, S., Hughes, G. J., & Weinberg, R. A. (1994) · Nature · doi:10.1038/371254a0 · Cited by 269
Bates, S., Bonetta, L. P., MacAllan, D., Parry, D., Holder, A. A., Dickson, C., & Peters, G. (1994) · PubMed · Cited by 260
Activation of cyclin-dependent kinase 4 (cdk4) by mouse MO15-associated kinase.
Matsuoka, M., Kato, J. Y., Fisher, R. P., Morgan, D. O., & Sherr, C. J. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7265 · Cited by 217
Self-citationHinds, P. W., & Weinberg, R. A. (1994) · Current Opinion in Genetics & Development · doi:10.1016/0959-437x(94)90102-3 · Cited by 207
Absence of cyclin D/cdk complexes in cells lacking functional retinoblastoma protein.
Bates, S., Parry, D., Bonetta, L. P., Vousden, K. H., Dickson, C., & Peters, G. (1994) · PubMed · Cited by 182
Fagan, R., Flint, K. J., & Jones, N. (1994) · Cell · doi:10.1016/s0092-8674(94)90522-3 · Cited by 160
Suppression of cyclin-dependent kinase 4 during induced differentiation of erythroleukemia cells.
Kiyokawa, H., Richon, V. M., Rifkind, R. A., & Marks, P. A. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.11.7195 · Cited by 99
Winston, J. T., & Pledger, W. J. (1993) · Molecular Biology of the Cell · doi:10.1091/mbc.4.11.1133 · Cited by 94
An E2F dominant negative mutant blocks E1A induced cell cycle progression.
Dobrowolski, S. F., Stacey, D. W., Harter, M. L., Stine, J. T., & Hiebert, S. W. (1994) · PubMed · Cited by 63
Research works printed but not linked: 9
- Jiang, 1993, Oncogene, 8, 3447
- Bates, 1994, Oncogene, 9, 71
- Won, 1992, 89, 9910
- Dobrowolski, 1994, Oncogene, 9, 2605
- Bates, 1994, Oncogene, 9, 1633
- Tam, 1994, Oncogene, 9, 2663
- Muller, 1994, 91, 2945
- Flores-Rozas, 1994, 91, 8655
- Li, 1994, Oncogene, 9, 2261
Cited by
Cell cycle, CDKs and cancer: a changing paradigm
Malumbres, M., & Barbacid, M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2602 · Cited by 3,957
Anticancer potential of curcumin: preclinical and clinical studies.
Aggarwal, B. B., Kumar, A. J., & Bharti, A. C. (2003) · PubMed · Cited by 3,017
The history and future of targeting cyclin-dependent kinases in cancer therapy
Asghar, U., Witkiewicz, A. K., Turner, N. C., & Knudsen, E. S. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4504 · Cited by 1,767
NF-κB Controls Cell Growth and Differentiation through Transcriptional Regulation of Cyclin D1
Guttridge, D. C., Albanese, C., Reuther, J. Y., Pestell, R. G., & Baldwin, A. S. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.8.5785 · Cited by 1,312
“The expression of cyclin D1 in G1 is important for cell cycle progression (60, 61), and results demonstrating that acceleration into S phase by cyclin D1 is greater for synchronized cultures emerging from quiescence than for asynchronous cycling cells suggest a specialized role for this D-type cyclin in the G0/G1 tran…”
BackgroundFry, D. W., Harvey, P. J., Keller, P. R., Elliott, W. L., Meade, M., Trachet, E., Albassam, M., Zheng, X., Leopold, W. R., Pryer, N. K., et al. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1427.3.11 · Cited by 1,236
“Progression through the G1-S phase requires phosphorylation of the retinoblastoma (Rb) protein by Cdk4 (7, 8) or the highly homologous enzyme Cdk6 (9, 10) in complex with their activating subunits, the D-type cyclins, D1, D2, or D3 (11).”
Background
Metadata
- Authors
- Sherr, C. J.
- Affiliations
- St. Jude Children's Research Hospital (US)
- Corresponding author
- Sherr, Charles J.
- ORCID
- Sherr, Charles J.
- Venue
- Trends in Biochemical Sciences
- Publisher
- Elsevier BV
- Published
- 1995-05
- Volume
- 20
- Issue
- 5
- Pages
- 187-190
- ISSN
- 0968-0004 (ISSN-L)
- OpenAlex
- W2155103945
- Cited by
- 980
- References
- 54
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 7 · 2023: 30 · 2022: 21 · 2021: 15 · 2020: 17 · 2019: 17 · 2018: 22 · 2017: 20 · 2016: 22 · 2015: 30 · 2014: 26 · 2013: 48 · 2012: 27
- FWCI
- 4.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- Locations
- Trends in Biochemical Sciences (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- D-type cyclins, cyclin-dependent kinases, CDK4, CDK6, G1 phase, cell cycle regulation, retinoblastoma protein, cyclin-dependent kinase inhibitors, S phase entry, growth factor signaling
- MeSH terms
- Animals, Oncogene Proteins, Cyclins, Cyclin-Dependent Kinases, Cyclin D1, Cyclin D2, Cyclin D3
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.